🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG

RecruitingNAAges 65 Years - 90 YearsAllNational Defense Medical Center, Taiwan
NCT07217236 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * At least one 12-lead ECG within 1 year Exclusion Criteria: * Diagnosis of sick sinus syndrome * Diagnosis of high-grade or complete atrioventricular block * Diagnosis of ventricular tachycardia or ventricular fibrillation * Post CIED implant * Heart rate below 40 beats per minute by 12-lead ECG
💊

What it tests

  • AI-ECG driven ECG monitoring
📍

Where

1 site
Tri-Service General Hospital
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy